Cholesterol and Heart Failure
Open accessThe claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A recent meta-analysis of available RCTs showed no reduction in mortality, myocardial infarction, or major vascular events associated with n-3 PUFAs, including in the subgroup of patients with known coronary artery disease.
“A recent meta-analysis of available RCTs showed no reduction in mortality, MI, or major vascular events associated with n-3 PUFAs, including the subgroup of patients with known CAD [453].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [453]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Rosuvastatin in older patients with systolic heart failure
Kjekshus, J., Apetrei, E., Barrios, V., Böhm, M., Cleland, J. G. F., Cornel, J. H., Dunselman, P., Fonseca, C., Goudev, A., Grande, P., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706201 · Cited by 1,487 · see citing works
GISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61240-4 · Cited by 1,106 · see citing works
PCSK9 (Proprotein convertase subtilisin/kexin type 9) inhibitors: past, present, and the future
Shimada, Y. J., & Cannon, C. P. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv174 · Cited by 111 · see citing works
Almontashiri, N. A. M., Vilmundarson, R. O., Ghasemzadeh, N., Dandona, S., Roberts, R., Quyyumi, A. A., Chen, H., & Stewart, A. F. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106294 · Cited by 109 · see citing works
Statins in Heart Failure: The Paradox Between Large Randomized Clinical Trials and Real Life
Gastelurrutia, P., Lupón, J., de Antonio, M., Urrútia, A., Díez, C., Coll, R., Altimir, S., & Bayés‐Genís, A. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2012.02.018 · Cited by 59 · see citing works
The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure
Bayés‐Genís, A., Núñez, J. E., Zannad, F. M., Ferreira, J. P., Anker, S. D., Cleland, J. G. F., Dickstein, K., Filippatos, G. S., Lang, C. C., Ng, L. L., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.08.057 · Cited by 59 · see citing works
Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure
Nymo, S. H., Aukrust, P., KJEKSHUS, J. K., McMurray, J. J. V., Cleland, J. G. F., Wikstrand, J., Muntendam, P., Wienhues‐Thelen, U., Latini, R., Askevold, E. T., et al. (2017) · JACC Heart Failure · doi:10.1016/j.jchf.2017.01.008 · Cited by 42 · see citing works
McCullough, P. A. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.04.056 · Cited by 27 · see citing works
PCSK9 Inhibitors and the Choice Between Innovation, Efficiency, and Affordability
Mark, D. B., & Schulman, K. A. (2017) · JAMA · doi:10.1001/jama.2017.8907 · Cited by 14 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961 · see citing works
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854 · see citing works
Egg consumption and cardiovascular risk: a dose–response meta-analysis of prospective cohort studies
Godos, J., Micek, A., Brzostek, T., Toledo, E., Iacoviello, L., Astrup, A. V., Franco, O. H., Galvano, F., Martínez‐González, M. Á., & Grosso, G. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02345-7 · Cited by 65 · see citing works
Alirocumab after acute coronary syndrome in patients with a history of heart failure
White, H. D., Schwartz, G. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Chiang, C.-E., Diaz, R., Goodman, S. G., Jukema, J. W., Loy, M., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehab804 · Cited by 41 · see citing works
Wang, X., Chen, Z., Tian, W., Zhang, J., Li, Q., Ju, J., Xu, H., & Chen, K. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1030257 · Cited by 19 · see citing works
Mendelian Randomization of Plasma Lipidome, Inflammatory Proteome and Heart Failure
Zheng, Z., & Tan, X. (2024) · ESC Heart Failure · doi:10.1002/ehf2.14997 · Cited by 8 · see citing works
Heart Failure Treatment in 2023: Is There a Place for Lipid Lowering Therapy?
Poloczková, H., & Krejčí, J. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01166-3 · Cited by 4 · see citing works
Biochemical profile and prognosis of patients with heart failure and diabetes
Марданов, Б. У., Kokozheva, M. A., & Мамедов, М. Н. (2020) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2020-3841 · Cited by 1 · see citing works
- Authors
- Francis, G. S.
- Affiliations
- University of Minnesota (US)
- Corresponding author
- Francis, Gary S.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2017-10
- Volume
- 70
- Issue
- 17
- Pages
- 2137-2138
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2766003365
- Cited by
- 8
- References
- 9
- Citations by year
- 2024: 1 · 2023: 2 · 2021: 1 · 2020: 2 · 2019: 2
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Keywords
- cholesterol, heart failure, chronic heart failure, PCSK9, LDL receptor, atherosclerosis progression, prognostic factors, lipid-lowering therapy
- MeSH terms
- Proprotein Convertase 9, Cholesterol, Heart Failure, Humans, Receptors, LDL
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
